2026-2030年全球醫療模擬市場

全球醫療模擬市場預計在 2025 年至 2030 年間成長至 32.542 億美元，預測期內複合年成長率為 16.3%。

這份關於全球醫療模擬市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：對病患安全的日益重視和減少醫療差錯的需求、虛擬實境 (VR) 和人工智慧 (AI) 技術的進步，以及基於能力的醫學教育和專業協作的轉變。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，設備小型化和向原位模擬的轉變是未來幾年全球醫療模擬市場成長的關鍵促進因素。此外，由於3D列印技術在創建患者特異性解剖模型方面的應用日益廣泛，以及模擬應用範圍從傳統臨床環境擴展到其他領域，因此預計市場需求也將顯著成長。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球醫療模擬市場
• 2020年至2024年最終用戶細分市場分析
• 基於解決方案的細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球醫療模擬市場
• 地緣政治衝突對全球醫療模擬市場的影響。

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 學術機構
• 軍事組織
• 醫院
• 其他
• 市場機會：依最終用戶分類

第9章 市場區隔：依解決方案

• 比較：按解決方案
• 醫學解剖模型
• 網路為基礎的模擬器
• 模擬訓練服務
• 醫學模擬軟體
• 市場機會：依解決方案分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 3D列印
• 虛擬病人模擬
• 程式演練技巧
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• 3B Scientific GmbH
• Anatomage Inc.
• Elevate Healthcare Inc.
• Gaumard Scientific Co. Inc.
• Kyoto Kagaku Co. Ltd.
• Laerdal Medical AS
• Limbs and Things Ltd.
• MedVision LLC
• Mentice AB
• Nasco Healthcare Inc.
• Oxford Medical Simulation Ltd.
• Surgical Science Sweden AB
• SynDaver Labs Inc.
• Trucorp Ltd.
• VirtaMed AG

第16章附錄

The global medical simulation market is forecasted to grow by USD 3254.2 mn during 2025-2030, accelerating at a CAGR of 16.3% during the forecast period. The report on the global medical simulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on patient safety and need to reduce medical errors, technological advancements in virtual reality and artificial intelligence, shift toward competency-based medical education and interprofessional collaboration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global medical simulation market is segmented as below:

By End-User

• Academic institutes
• Military organizations
• Hospitals
• Others

By Solution

• Healthcare anatomical models
• Web-based simulators
• Simulation training services
• Healthcare simulation software

By Technology

• 3D printing
• Virtual patient simulation
• Procedural rehearsal technology

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the miniaturization of equipment and transition toward in-situ simulation as one of the prime reasons driving the global medical simulation market growth during the next few years. Also, increasing adoption of 3d printing for patient specific anatomical models and expansion of simulation applications beyond traditional clinical settings will lead to sizable demand in the market.

The report on the global medical simulation market covers the following areas:

• Global medical simulation market sizing
• Global medical simulation market forecast
• Global medical simulation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global medical simulation market vendors that include 3B Scientific GmbH, Anatomage Inc., Avkin Inc., Elevate Healthcare Inc., Gaumard Scientific Co. Inc., Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Limbs and Things Ltd., Medical X, MedVision LLC, Mentice AB, Nasco Healthcare Inc., Operative Experience Inc., Oxford Medical Simulation Ltd., Simulab Corp., SimX Inc, Surgical Science Sweden AB, SynDaver Labs Inc., Trucorp Ltd., VirtaMed AG. Also, the global medical simulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Solution
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Medical Simulation Market 2020 - 2024
  • Historic Market Size - Data Table on Global Medical Simulation Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Solution segment analysis 2020 - 2024
  • Historic Market Size - Solution Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global medical simulation market
• 6.2 Impact of geopolitical conflicts on global medical simulation market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Academic institutes - Market size and forecast 2025-2030
• 8.4 Military organizations - Market size and forecast 2025-2030
• 8.5 Hospitals - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Solution

• 9.1 Market segments
• 9.2 Comparison by Solution
• 9.3 Healthcare anatomical models - Market size and forecast 2025-2030
• 9.4 Web-based simulators - Market size and forecast 2025-2030
• 9.5 Simulation training services - Market size and forecast 2025-2030
• 9.6 Healthcare simulation software - Market size and forecast 2025-2030
• 9.7 Market opportunity by Solution
  • Market opportunity by Solution ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 3D printing - Market size and forecast 2025-2030
• 10.4 Virtual patient simulation - Market size and forecast 2025-2030
• 10.5 Procedural rehearsal technology - Market size and forecast 2025-2030
• 10.6 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing focus on patient safety and need to reduce medical errors
  • Technological advancements in virtual reality and artificial intelligence
  • Shift toward competency-based medical education and interprofessional collaboration
• 13.2 Market challenges
  • High capital investment and ongoing operational costs
  • Scarcity of qualified simulation instructors and specialized technicians
  • Lack of standardization in simulation curricula and assessment metrics
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Miniaturization of equipment and transition toward In-Situ simulation
  • Increasing adoption of 3D printing for patient specific anatomical models
  • Expansion of simulation applications beyond traditional clinical settings

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 3B Scientific GmbH
  • 3B Scientific GmbH - Overview
  • 3B Scientific GmbH - Product / Service
  • 3B Scientific GmbH - Key offerings
  • SWOT
• 15.5 Anatomage Inc.
  • Anatomage Inc. - Overview
  • Anatomage Inc. - Product / Service
  • Anatomage Inc. - Key offerings
  • SWOT
• 15.6 Elevate Healthcare Inc.
  • Elevate Healthcare Inc. - Overview
  • Elevate Healthcare Inc. - Product / Service
  • Elevate Healthcare Inc. - Key offerings
  • SWOT
• 15.7 Gaumard Scientific Co. Inc.
  • Gaumard Scientific Co. Inc. - Overview
  • Gaumard Scientific Co. Inc. - Product / Service
  • Gaumard Scientific Co. Inc. - Key offerings
  • SWOT
• 15.8 Kyoto Kagaku Co. Ltd.
  • Kyoto Kagaku Co. Ltd. - Overview
  • Kyoto Kagaku Co. Ltd. - Product / Service
  • Kyoto Kagaku Co. Ltd. - Key offerings
  • SWOT
• 15.9 Laerdal Medical AS
  • Laerdal Medical AS - Overview
  • Laerdal Medical AS - Product / Service
  • Laerdal Medical AS - Key offerings
  • SWOT
• 15.10 Limbs and Things Ltd.
  • Limbs and Things Ltd. - Overview
  • Limbs and Things Ltd. - Product / Service
  • Limbs and Things Ltd. - Key offerings
  • SWOT
• 15.11 MedVision LLC
  • MedVision LLC - Overview
  • MedVision LLC - Product / Service
  • MedVision LLC - Key offerings
  • SWOT
• 15.12 Mentice AB
  • Mentice AB - Overview
  • Mentice AB - Business segments
  • Mentice AB - Key offerings
  • Mentice AB - Segment focus
  • SWOT
• 15.13 Nasco Healthcare Inc.
  • Nasco Healthcare Inc. - Overview
  • Nasco Healthcare Inc. - Product / Service
  • Nasco Healthcare Inc. - Key offerings
  • SWOT
• 15.14 Oxford Medical Simulation Ltd.
  • Oxford Medical Simulation Ltd. - Overview
  • Oxford Medical Simulation Ltd. - Product / Service
  • Oxford Medical Simulation Ltd. - Key offerings
  • SWOT
• 15.15 Surgical Science Sweden AB
  • Surgical Science Sweden AB - Overview
  • Surgical Science Sweden AB - Business segments
  • Surgical Science Sweden AB - Key offerings
  • Surgical Science Sweden AB - Segment focus
  • SWOT
• 15.16 SynDaver Labs Inc.
  • SynDaver Labs Inc. - Overview
  • SynDaver Labs Inc. - Product / Service
  • SynDaver Labs Inc. - Key offerings
  • SWOT
• 15.17 Trucorp Ltd.
  • Trucorp Ltd. - Overview
  • Trucorp Ltd. - Product / Service
  • Trucorp Ltd. - Key offerings
  • SWOT
• 15.18 VirtaMed AG
  • VirtaMed AG - Overview
  • VirtaMed AG - Product / Service
  • VirtaMed AG - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations